| Description | PDE1-IN-1can enhance levels of the second messengers cAMP/cGMP leading to the expression of neuronal plasticity-related genes, neurotrophic factors, and neuroprotective molecules. These neuronal plasticity enhancement properties make PDE1 inhibitors good candidates as therapeutic agents in many neurological conditions. |
| molecular weight | 501.62 |
| Molecular formula | C32H31N5O |
| CAS | 191982-37-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |